Ottawa – The Patented Medicine Prices Review Board (PMPRB) published the 8th edition of its annual Meds Entry Watch report today. The analysis finds that the number of new medicines launched in Canada is higher than the median for Organisation for Economic Co-operation and Development (OECD) countries., Most new medicines come to market with high treatment costs, and specialty medicines such as biologic, …
PMPRB report: Most new meds in market have high treatment costs
Ottawa – The Patented Medicine Prices Review Board (PMPRB) published today the 7th edition of its annual Meds Entry Watch report. The analysis finds that the number of new medicines launched in Canada is higher than the median for Organisation for Economic Co-operation and Development (OECD) countries but falls below the median of the eleven PMPRB comparators, all of which have lower average …
Strict regulation needed for Ozempic
London – As reports of self-inflicted harm and suicidal thoughts have increased among those who use Ozempic or Wegovy in Europe and the United Kingdom, health regulators are looking at potential risk of adverse effects linked to these drugs. The European Medicines Agency said it was evaluating 150 such cases. These drugs are known to reduce blood sugar levels and …